Knockdown of LDHA in tumor cells using RNAi nanoparticles neutralized the pH of the TME, increased infiltration with CD8+ T and NK cells, decreased the number of Tregs, significantly inhibited the growth of tumors and potentiated checkpoint inhibition therapy (105). The gene discussed is LDHA; the disease is neoplasm.